Replies to post #63 on RetinalGeniX Technologies Inc (RTGN)

[~S.B.A.~]

Good to see volume. Company needs PR/IR to capitalize on antibiotic resistance. I would imagine with a new issue an IR/PR plan has already been established. Question is when will we see the rollout of such plans?